table of content
1 Introduction to Research & Analysis Reports
1.1 Radiopharmaceuticals in Nuclear Medicine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Radiopharmaceuticals in Nuclear Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Radiopharmaceuticals in Nuclear Medicine Overall Market Size
2.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size: 2023 VS 2030
2.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Radiopharmaceuticals in Nuclear Medicine Sales: 2019-2030
3 Company Landscape
3.1 Top Radiopharmaceuticals in Nuclear Medicine Players in Global Market
3.2 Top Global Radiopharmaceuticals in Nuclear Medicine Companies Ranked by Revenue
3.3 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Companies
3.4 Global Radiopharmaceuticals in Nuclear Medicine Sales by Companies
3.5 Global Radiopharmaceuticals in Nuclear Medicine Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Radiopharmaceuticals in Nuclear Medicine Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Radiopharmaceuticals in Nuclear Medicine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Radiopharmaceuticals in Nuclear Medicine Players in Global Market
3.8.1 List of Global Tier 1 Radiopharmaceuticals in Nuclear Medicine Companies
3.8.2 List of Global Tier 2 and Tier 3 Radiopharmaceuticals in Nuclear Medicine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Radiopharmaceuticals in Nuclear Medicine Market Size Markets, 2023 & 2030
4.1.2 Diagnostic Radiopharmaceuticals
4.1.3 Therapy Radiopharmaceuticals
4.1.4 Enriched Stable Isotopes
4.2 By Type - Global Radiopharmaceuticals in Nuclear Medicine Revenue & Forecasts
4.2.1 By Type - Global Radiopharmaceuticals in Nuclear Medicine Revenue, 2019-2024
4.2.2 By Type - Global Radiopharmaceuticals in Nuclear Medicine Revenue, 2025-2030
4.2.3 By Type - Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share, 2019-2030
4.3 By Type - Global Radiopharmaceuticals in Nuclear Medicine Sales & Forecasts
4.3.1 By Type - Global Radiopharmaceuticals in Nuclear Medicine Sales, 2019-2024
4.3.2 By Type - Global Radiopharmaceuticals in Nuclear Medicine Sales, 2025-2030
4.3.3 By Type - Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share, 2019-2030
4.4 By Type - Global Radiopharmaceuticals in Nuclear Medicine Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Radiopharmaceuticals in Nuclear Medicine Market Size, 2023 & 2030
5.1.2 Diagnostic Application
5.1.3 Therapeutic Application
5.1.4 Research
5.1.5 Pharmaceutical
5.1.6 Other
5.2 By Application - Global Radiopharmaceuticals in Nuclear Medicine Revenue & Forecasts
5.2.1 By Application - Global Radiopharmaceuticals in Nuclear Medicine Revenue, 2019-2024
5.2.2 By Application - Global Radiopharmaceuticals in Nuclear Medicine Revenue, 2025-2030
5.2.3 By Application - Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share, 2019-2030
5.3 By Application - Global Radiopharmaceuticals in Nuclear Medicine Sales & Forecasts
5.3.1 By Application - Global Radiopharmaceuticals in Nuclear Medicine Sales, 2019-2024
5.3.2 By Application - Global Radiopharmaceuticals in Nuclear Medicine Sales, 2025-2030
5.3.3 By Application - Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share, 2019-2030
5.4 By Application - Global Radiopharmaceuticals in Nuclear Medicine Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Radiopharmaceuticals in Nuclear Medicine Market Size, 2023 & 2030
6.2 By Region - Global Radiopharmaceuticals in Nuclear Medicine Revenue & Forecasts
6.2.1 By Region - Global Radiopharmaceuticals in Nuclear Medicine Revenue, 2019-2024
6.2.2 By Region - Global Radiopharmaceuticals in Nuclear Medicine Revenue, 2025-2030
6.2.3 By Region - Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share, 2019-2030
6.3 By Region - Global Radiopharmaceuticals in Nuclear Medicine Sales & Forecasts
6.3.1 By Region - Global Radiopharmaceuticals in Nuclear Medicine Sales, 2019-2024
6.3.2 By Region - Global Radiopharmaceuticals in Nuclear Medicine Sales, 2025-2030
6.3.3 By Region - Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Radiopharmaceuticals in Nuclear Medicine Revenue, 2019-2030
6.4.2 By Country - North America Radiopharmaceuticals in Nuclear Medicine Sales, 2019-2030
6.4.3 US Radiopharmaceuticals in Nuclear Medicine Market Size, 2019-2030
6.4.4 Canada Radiopharmaceuticals in Nuclear Medicine Market Size, 2019-2030
6.4.5 Mexico Radiopharmaceuticals in Nuclear Medicine Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Radiopharmaceuticals in Nuclear Medicine Revenue, 2019-2030
6.5.2 By Country - Europe Radiopharmaceuticals in Nuclear Medicine Sales, 2019-2030
6.5.3 Germany Radiopharmaceuticals in Nuclear Medicine Market Size, 2019-2030
6.5.4 France Radiopharmaceuticals in Nuclear Medicine Market Size, 2019-2030
6.5.5 U.K. Radiopharmaceuticals in Nuclear Medicine Market Size, 2019-2030
6.5.6 Italy Radiopharmaceuticals in Nuclear Medicine Market Size, 2019-2030
6.5.7 Russia Radiopharmaceuticals in Nuclear Medicine Market Size, 2019-2030
6.5.8 Nordic Countries Radiopharmaceuticals in Nuclear Medicine Market Size, 2019-2030
6.5.9 Benelux Radiopharmaceuticals in Nuclear Medicine Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Radiopharmaceuticals in Nuclear Medicine Revenue, 2019-2030
6.6.2 By Region - Asia Radiopharmaceuticals in Nuclear Medicine Sales, 2019-2030
6.6.3 China Radiopharmaceuticals in Nuclear Medicine Market Size, 2019-2030
6.6.4 Japan Radiopharmaceuticals in Nuclear Medicine Market Size, 2019-2030
6.6.5 South Korea Radiopharmaceuticals in Nuclear Medicine Market Size, 2019-2030
6.6.6 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Market Size, 2019-2030
6.6.7 India Radiopharmaceuticals in Nuclear Medicine Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Radiopharmaceuticals in Nuclear Medicine Revenue, 2019-2030
6.7.2 By Country - South America Radiopharmaceuticals in Nuclear Medicine Sales, 2019-2030
6.7.3 Brazil Radiopharmaceuticals in Nuclear Medicine Market Size, 2019-2030
6.7.4 Argentina Radiopharmaceuticals in Nuclear Medicine Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales, 2019-2030
6.8.3 Turkey Radiopharmaceuticals in Nuclear Medicine Market Size, 2019-2030
6.8.4 Israel Radiopharmaceuticals in Nuclear Medicine Market Size, 2019-2030
6.8.5 Saudi Arabia Radiopharmaceuticals in Nuclear Medicine Market Size, 2019-2030
6.8.6 UAE Radiopharmaceuticals in Nuclear Medicine Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Bracco Imaging S.P.A.
7.1.1 Bracco Imaging S.P.A. Company Summary
7.1.2 Bracco Imaging S.P.A. Business Overview
7.1.3 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.1.4 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2019-2024)
7.1.5 Bracco Imaging S.P.A. Key News & Latest Developments
7.2 Cambridge Isotope Laboratories, Inc.
7.2.1 Cambridge Isotope Laboratories, Inc. Company Summary
7.2.2 Cambridge Isotope Laboratories, Inc. Business Overview
7.2.3 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.2.4 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2019-2024)
7.2.5 Cambridge Isotope Laboratories, Inc. Key News & Latest Developments
7.3 Cardinal Health, Inc.
7.3.1 Cardinal Health, Inc. Company Summary
7.3.2 Cardinal Health, Inc. Business Overview
7.3.3 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.3.4 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2019-2024)
7.3.5 Cardinal Health, Inc. Key News & Latest Developments
7.4 Covidien, Plc
7.4.1 Covidien, Plc Company Summary
7.4.2 Covidien, Plc Business Overview
7.4.3 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.4.4 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2019-2024)
7.4.5 Covidien, Plc Key News & Latest Developments
7.5 Eczacibasi-Monrol
7.5.1 Eczacibasi-Monrol Company Summary
7.5.2 Eczacibasi-Monrol Business Overview
7.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.5.4 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2019-2024)
7.5.5 Eczacibasi-Monrol Key News & Latest Developments
7.6 Fujifilm Holdings Corporation
7.6.1 Fujifilm Holdings Corporation Company Summary
7.6.2 Fujifilm Holdings Corporation Business Overview
7.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.6.4 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2019-2024)
7.6.5 Fujifilm Holdings Corporation Key News & Latest Developments
7.7 GE Healthcare (Subsidiary Of General Electric Company)
7.7.1 GE Healthcare (Subsidiary Of General Electric Company) Company Summary
7.7.2 GE Healthcare (Subsidiary Of General Electric Company) Business Overview
7.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.7.4 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2019-2024)
7.7.5 GE Healthcare (Subsidiary Of General Electric Company) Key News & Latest Developments
7.8 IBA Group
7.8.1 IBA Group Company Summary
7.8.2 IBA Group Business Overview
7.8.3 IBA Group Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.8.4 IBA Group Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2019-2024)
7.8.5 IBA Group Key News & Latest Developments
7.9 Isotec, Inc. (Sigma-Aldrich)
7.9.1 Isotec, Inc. (Sigma-Aldrich) Company Summary
7.9.2 Isotec, Inc. (Sigma-Aldrich) Business Overview
7.9.3 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.9.4 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2019-2024)
7.9.5 Isotec, Inc. (Sigma-Aldrich) Key News & Latest Developments
7.10 Lantheus Medical Imaging, Inc.
7.10.1 Lantheus Medical Imaging, Inc. Company Summary
7.10.2 Lantheus Medical Imaging, Inc. Business Overview
7.10.3 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.10.4 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2019-2024)
7.10.5 Lantheus Medical Imaging, Inc. Key News & Latest Developments
7.11 Nordion, Inc.
7.11.1 Nordion, Inc. Company Summary
7.11.2 Nordion, Inc. Business Overview
7.11.3 Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.11.4 Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2019-2024)
7.11.5 Nordion, Inc. Key News & Latest Developments
7.12 Ntp Radioisotopes (Pty), Ltd.
7.12.1 Ntp Radioisotopes (Pty), Ltd. Company Summary
7.12.2 Ntp Radioisotopes (Pty), Ltd. Business Overview
7.12.3 Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.12.4 Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2019-2024)
7.12.5 Ntp Radioisotopes (Pty), Ltd. Key News & Latest Developments
7.13 Siemens Healthcare (Subsidiary Of Siemens AG)
7.13.1 Siemens Healthcare (Subsidiary Of Siemens AG) Company Summary
7.13.2 Siemens Healthcare (Subsidiary Of Siemens AG) Business Overview
7.13.3 Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.13.4 Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2019-2024)
7.13.5 Siemens Healthcare (Subsidiary Of Siemens AG) Key News & Latest Developments
7.14 Taiyo Nippon Sanso Corporation
7.14.1 Taiyo Nippon Sanso Corporation Company Summary
7.14.2 Taiyo Nippon Sanso Corporation Business Overview
7.14.3 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.14.4 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2019-2024)
7.14.5 Taiyo Nippon Sanso Corporation Key News & Latest Developments
7.15 Urenco Limited
7.15.1 Urenco Limited Company Summary
7.15.2 Urenco Limited Business Overview
7.15.3 Urenco Limited Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.15.4 Urenco Limited Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2019-2024)
7.15.5 Urenco Limited Key News & Latest Developments
7.16 Rotem Industries, Ltd., Inc.
7.16.1 Rotem Industries, Ltd., Inc. Company Summary
7.16.2 Rotem Industries, Ltd., Inc. Business Overview
7.16.3 Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.16.4 Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2019-2024)
7.16.5 Rotem Industries, Ltd., Inc. Key News & Latest Developments
7.17 Australian Nuclear Association And Technology Organization (ANSTO)
7.17.1 Australian Nuclear Association And Technology Organization (ANSTO) Company Summary
7.17.2 Australian Nuclear Association And Technology Organization (ANSTO) Business Overview
7.17.3 Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.17.4 Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2019-2024)
7.17.5 Australian Nuclear Association And Technology Organization (ANSTO) Key News & Latest Developments
7.18 Board of Radiation And Isotope Technology (BRIT)
7.18.1 Board of Radiation And Isotope Technology (BRIT) Company Summary
7.18.2 Board of Radiation And Isotope Technology (BRIT) Business Overview
7.18.3 Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.18.4 Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2019-2024)
7.18.5 Board of Radiation And Isotope Technology (BRIT) Key News & Latest Developments
7.19 Institute of Atomic Energy Polatom Radioisotope Centre
7.19.1 Institute of Atomic Energy Polatom Radioisotope Centre Company Summary
7.19.2 Institute of Atomic Energy Polatom Radioisotope Centre Business Overview
7.19.3 Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.19.4 Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2019-2024)
7.19.5 Institute of Atomic Energy Polatom Radioisotope Centre Key News & Latest Developments
7.20 Institute of Isotopes Co., Ltd.
7.20.1 Institute of Isotopes Co., Ltd. Company Summary
7.20.2 Institute of Isotopes Co., Ltd. Business Overview
7.20.3 Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.20.4 Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2019-2024)
7.20.5 Institute of Isotopes Co., Ltd. Key News & Latest Developments
7.21 Institute Of Radioelement (IRE)
7.21.1 Institute Of Radioelement (IRE) Company Summary
7.21.2 Institute Of Radioelement (IRE) Business Overview
7.21.3 Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.21.4 Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2019-2024)
7.21.5 Institute Of Radioelement (IRE) Key News & Latest Developments
8 Global Radiopharmaceuticals in Nuclear Medicine Production Capacity, Analysis
8.1 Global Radiopharmaceuticals in Nuclear Medicine Production Capacity, 2019-2030
8.2 Radiopharmaceuticals in Nuclear Medicine Production Capacity of Key Manufacturers in Global Market
8.3 Global Radiopharmaceuticals in Nuclear Medicine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Radiopharmaceuticals in Nuclear Medicine Supply Chain Analysis
10.1 Radiopharmaceuticals in Nuclear Medicine Industry Value Chain
10.2 Radiopharmaceuticals in Nuclear Medicine Upstream Market
10.3 Radiopharmaceuticals in Nuclear Medicine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Radiopharmaceuticals in Nuclear Medicine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
